PHARMACAPS
Banner Pharmacaps Inc.
Application Filed: 2009-04-24
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77721772 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Maury M. Tepper, III |
| Attorney Docket Number | 04700.1.4 |
| Law Office Assigned | M20 |
| Employee Name | WHITTAKER BROWN, TRACY |
Timeline
| 2009-04-24 | Application Filed |
| 2010-05-11 | Published for Opposition |
| 2011-07-07 | Location: INTENT TO USE SECTION |
| 2013-08-05 | Abandon |
| 2013-08-05 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Banner Pharmacaps Inc. |
| Address | 4125 Premier Drive High Point DE 27265 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | soft gelatin and non-animal film encapsulations and hard core enrobements for various pharmaceutical preparations, namely, aids related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; soft gelatin and non-animal film encapsulations and hard core enrobements for cardiovascular agents, namely, calcium channel blockers for heart disease; soft gelatin and non-animal film encapsulations and hard core enrobements for gastrointestinal preparations, namely, preparations for the treatment of flatulence and constipation; soft gelatin and non-animal film encapsulations and hard core enrobements for musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; soft gelatin and non-animal film encapsulations and hard core enrobements for transplant and immunosuppressant preparations, namely, cyclosporine; soft gelatin and non-animal film encapsulations and hard core enrobements for pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; soft gelatin and non-animal film encapsulations and hard core enrobements for natural medicine preparations, namely, herbal supplements; soft gelatin and non-animal film encapsulations and hard core enrobements for vitamin, mineral and nutritional supplements; pharmaceutical preparations, namely, AIDS related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; cardiovascular agents, namely, calcium channel blockers for heart disease; gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; transplant and immunosuppressant preparations, namely, cyclosporine; pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; natural medicine products, namely, herbal supplements; vitamin, mineral and nutritional supplements |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2009-04-28 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-04-28 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK MAILED | 2009-04-29 | 3 MPMK O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2009-07-07 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2009-07-11 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2009-07-11 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2009-07-11 | 7 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-07-11 | 8 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-07-11 | 9 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-11-23 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-11-23 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-11-23 | 12 TEME I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-12-01 | 13 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-12-01 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-12-01 | 15 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2009-12-30 | 16 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2009-12-30 | 17 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2009-12-30 | 18 GNRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2010-03-19 | 19 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2010-03-19 | 20 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2010-03-19 | 21 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2010-03-19 | 22 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-03-20 | 23 CNSA P: |
| ASSIGNED TO LIE | 2010-04-07 | 24 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-04-07 | 25 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2010-05-11 | 26 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-05-11 | 27 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2010-07-06 | 28 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2011-01-04 | 29 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2011-01-04 | 30 EXT1 S: |
| EXTENSION 1 GRANTED | 2011-01-04 | 31 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2011-01-06 | 32 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2011-07-06 | 33 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2011-07-07 | 34 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2011-07-06 | 35 EXT2 S: |
| EXTENSION 2 GRANTED | 2011-07-11 | 36 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2011-07-12 | 37 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2012-01-04 | 38 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2012-01-04 | 39 EXT3 S: |
| EXTENSION 3 GRANTED | 2012-01-11 | 40 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-01-12 | 41 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2012-07-03 | 42 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2012-07-03 | 43 EXT4 S: |
| EXTENSION 4 GRANTED | 2012-07-06 | 44 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-07-07 | 45 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2012-12-20 | 46 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2012-12-20 | 47 EXT5 S: |
| EXTENSION 5 GRANTED | 2012-12-26 | 48 EX5G S: |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2012-12-26 | 49 ASCK I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2012-12-27 | 50 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2013-08-05 | 51 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2013-08-05 | 52 MAB6 O:Outgoing Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2014-04-30 | 53 ASCK I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PHARMACAPS 86006722 not registered Dead/Abandoned |
Banner Pharmacaps Inc. 2013-07-10 |
 PHARMACAPS 77721772 not registered Dead/Abandoned |
Banner Pharmacaps Inc. 2009-04-24 |
 PHARMACAPS 73068003 1064790 Dead/Cancelled |
Pharmacaps, Inc. 1975-11-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 